(Q36910441)

17 August 2017

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia (English)

1 reference

17 August 2017

chronic myeloid leukemia

0 references

leukemia

1 reference

chronic myelomonocytic leukemia

inferred from title

1 reference

11

Hagop Kantarjian

1 reference

17 August 2017

10

Elias Jabbour

1 reference

17 August 2017

Guillermo Garcia-Manero

1

object named as

Guillermo Garcia-Manero

1 reference

17 August 2017

7

Eric Laille

1 reference

17 August 2017

12

Barry Skikne

1 reference

17 August 2017

Steven D Gore

2

1 reference

17 August 2017

Christopher Cogle

3

1 reference

17 August 2017

Renee Ward

4

1 reference

17 August 2017

Tao Shi

5

1 reference

17 August 2017

Kyle J Macbeth

6

1 reference

17 August 2017

Heidi Giordano

8

1 reference

17 August 2017

Sarah Sakoian

9

1 reference

17 August 2017

language of work or name

English

0 references

publication date

16 May 2011

1 reference

Journal of Clinical Oncology

17 August 2017

1 reference

17 August 2017

29

1 reference

17 August 2017

18

1 reference

17 August 2017

2521-2527

1 reference

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

Azacytidine causes complex DNA methylation responses in myeloid leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

A pilot pharmacokinetic study of oral azacitidine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

The World Health Organization (WHO) classification of the myeloid neoplasms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

Missing value estimation methods for DNA microarrays

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

International scoring system for evaluating prognosis in myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675699

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21576646

12 December 2020

inferred from PubMed ID database lookup

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21576646

12 December 2020

inferred from PubMed ID database lookup

Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21576646

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1200/JCO.2010.34.4226

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

21576646

1 reference